DrugPatentWatch Database Preview
Details for Patent: 9,757,416
Email this page to a colleague
» See Plans and PricingWhich drugs does patent 9,757,416 protect, and when does it expire?
Patent 9,757,416 protects AURYXIA and is included in one NDA.
This patent has eighty-five patent family members in twenty countries.
Summary for Patent: 9,757,416
| Title: | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| Abstract: | The present invention discloses pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A manufacturing and quality control process for making a pharmaceutical-grade ferric citrate that consistently complies with the established Manufacture Release Specification is also disclosed. The pharmaceutical-grade ferric organic compounds are suitable for treating disorders characterized by elevated serum phosphate levels. |
| Inventor(s): | Chan; Keith (Rockville, MD), Town; Winston (Hong Kong, CN), Kwok; David W. K. (Vancouver, CA), Stoynov; Nikolay Mintchev (Vancouver, CA) |
| Assignee: | Panion & BF Biotech Inc. (TW) |
| Application Number: | 14/701,933 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,757,416 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 9,757,416
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | CONTROL OF SERUM PHOSPHOROUS LEVELS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,757,416
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004213819 | Start Trial | |||
| Australia | 2006279333 | Start Trial | |||
| Australia | 2007210090 | Start Trial | |||
| Australia | 2007210096 | Start Trial | |||
| Canada | 2516471 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
